JAMA

JAMA JAMA is an international peer-reviewed general medical journal published weekly online and in print.

The official page for JAMA http://jama.com, an international, peer-reviewed journal published weekly online and in print.

"As a mother and an obstetrician, these are the hardest rooms that I enter, the most difficult places that I hold in my ...
04/02/2026

"As a mother and an obstetrician, these are the hardest rooms that I enter, the most difficult places that I hold in my heart. We are the only place in the hospital to have this signal. It sets us apart, this reminder of fragile lives that sometimes end before they even truly begin. "

In , an discusses the way in which it is not only the joy of patients, but also the grief, that keeps her going.

https://ja.ma/4dqXBLi

💬 Viewpoint by Hamlet Gasoyan, DS, PhD, MPH, and Michael Rothberg, MD, MPH: The Centers for Medicare & Medicaid Services...
04/02/2026

💬 Viewpoint by Hamlet Gasoyan, DS, PhD, MPH, and Michael Rothberg, MD, MPH:

The Centers for Medicare & Medicaid Services Better Approaches to Lifestyle and Nutrition for Comprehensive Health (CMS BALANCE) model aims to expand access to -1 agonists and lifestyle interventions for Medicare and Medicaid beneficiaries.

The policy establishes standardized coverage terms, pricing negotiations, and a Part D bridge program, offering $50 monthly co-pay access starting July 2026.

While the model addresses coverage gaps and prior authorization burden, program success depends on broad participation from states and Part D plans given ongoing budget concerns and varying Medicaid coverage trends.

https://ja.ma/4tsKE8v

Medicare price agreements established under the CMS BALANCE model set the net cost for at $245 per month for plans cov...
04/02/2026

Medicare price agreements established under the CMS BALANCE model set the net cost for at $245 per month for plans covering obesity and related comorbidities, compared to negotiated maximum fair prices ($277 for Ozempic and $386 for Wegovy) via the Inflation Reduction Act.

Modeling based on current utilization suggests these price reductions could generate $932.7 million in savings, sufficient to offset treatment costs for approximately 550 000 additional beneficiaries eligible for expanded coverage.

Plan participation remains a limiting factor, and wider uptake may require additional incentives or negotiation.

https://ja.ma/4bOdCJT

💬 Viewpoint: Linking equity, patient-centeredness, and technical progress as interconnected goals—rather than isolated f...
04/02/2026

💬 Viewpoint: Linking equity, patient-centeredness, and technical progress as interconnected goals—rather than isolated fixes—is required to transform US health care beyond incremental improvement.

https://ja.ma/4skjYpy

💬 Perspective: The dominance of EHR vendor models may reduce incentives for innovation and diversity among third-party...
04/02/2026

💬 Perspective: The dominance of EHR vendor models may reduce incentives for innovation and diversity among third-party health AI tools, raising questions for policymakers.

https://ja.ma/41Gpc3J

📊 JAMA Clinical Guidelines Synopsis: The 2024 guideline from the American Heart Association and American College of Card...
04/02/2026

📊 JAMA Clinical Guidelines Synopsis: The 2024 guideline from the American Heart Association and American College of Cardiology addresses perioperative cardiovascular medication management for adult patients undergoing noncardiac surgery.

Recommendations include continuing statins and β-blockers for patients already receiving them, initiating statins in those with established or elevated atherosclerotic cardiovascular disease risk, and withholding sodium-glucose cotransporter 2 (SGLT-2) inhibitors 3-4 days before surgery to reduce metabolic acidosis risk.

Perioperative aspirin is recommended only for patients with prior percutaneous coronary intervention, with initiation discouraged for others due to increased bleeding risk.

https://ja.ma/4deeEQx

04/02/2026

What is a clinical decision support system? 🤖

A clinical decision support system ( ) is an tool that assists clinicians by analyzing medical data and providing evidence-based recommendations for diagnosis and treatment.

JAMA+ AI highlights the role of artificial intelligence and digital medicine in health care, drawing on original research, editorials, and medical news from across the JAMA Network.

🔗 To learn more about in clinical settings, visit JAMA+ AI: https://ja.ma/4rYNPn2

💬 Editorial by Aaron Tierney, PhD, Kristine Lee, MD, and Vincent Liu, MD, MS: Ambient artificial intelligence ( ) scribe...
04/01/2026

💬 Editorial by Aaron Tierney, PhD, Kristine Lee, MD, and Vincent Liu, MD, MS:

Ambient artificial intelligence ( ) scribes are now integrated into clinical workflows and demonstrate consistent reductions in documentation-related workload, including EHR and note completion time, as confirmed by multicenter evaluations.

Time savings are most pronounced for clinicians with high-frequency use and certain subgroups such as advanced practice clinicians and residents.

As ambient AI becomes widespread, current measurements emphasize workflow and productivity but lack robust assessment of effects on patient experience, population outcomes, and health equity, domains central to the quintuple aim.

https://ja.ma/3Odrggz

A multisite longitudinal cohort study at 5 US academic health centers found that adoption of artificial intelligence–ena...
04/01/2026

A multisite longitudinal cohort study at 5 US academic health centers found that adoption of artificial intelligence–enabled scribe technology was associated with modest reductions in electronic health record (EHR) and documentation time and a small increase in weekly visit volume.

Time savings were greatest among primary care specialists, advanced practice clinicians, female clinicians, and those using scribes in ≥50% of visits.

EHR time outside scheduled hours was not significantly affected, highlighting that AI scribe adoption may selectively benefit certain clinician groups and workflows.

https://ja.ma/4sNrIkT

💬 Viewpoint: Breast density increases cancer risk and reduces sensitivity, but access to supplemental screening like ...
04/01/2026

💬 Viewpoint: Breast density increases cancer risk and reduces sensitivity, but access to supplemental screening like and ultrasonography remains limited, creating disparities in early detection.

https://ja.ma/4bXQozY

📊 JAMA Clinical Guidelines Synopsis: The 2025 guideline for management recommends dual antiplatelet therapy with aspir...
04/01/2026

📊 JAMA Clinical Guidelines Synopsis: The 2025 guideline for management recommends dual antiplatelet therapy with aspirin and a P2Y12 inhibitor, high-intensity statins, invasive revascularization, and radial access for angiography.

https://ja.ma/48iqi9y

Bone lead levels were directly associated with higher mortality, and lead was the eighth leading cause of death worldw...
04/01/2026

Bone lead levels were directly associated with higher mortality, and lead was the eighth leading cause of death worldwide and second among environmental risks in 2023.

https://ja.ma/3QaWy8m

Address

330 N Wabash Avenue
Chicago, IL
60611

Telephone

+13126707827

Website

Alerts

Be the first to know and let us send you an email when JAMA posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category